<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>49(4)</volume><submitter>Pilgram L</submitter><funding>Universitätsklinikum Essen</funding><pubmed_abstract>&lt;h4>Purpose&lt;/h4>The ongoing pandemic caused by the novel severe acute respiratory coronavirus 2 (SARS-CoV-2) has stressed health systems worldwide. Patients with chronic kidney disease (CKD) seem to be more prone to a severe course of coronavirus disease (COVID-19) due to comorbidities and an altered immune system. The study's aim was to identify factors predicting mortality among SARS-CoV-2-infected patients with CKD.&lt;h4>Methods&lt;/h4>We analyzed 2817 SARS-CoV-2-infected patients enrolled in the Lean European Open Survey on SARS-CoV-2-infected patients and identified 426 patients with pre-existing CKD. Group comparisons were performed via Chi-squared test. Using univariate and multivariable logistic regression, predictive factors for mortality were identified.&lt;h4>Results&lt;/h4>Comparative ana</pubmed_abstract><journal>Infection</journal><pagination>725-737</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8043429</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease.</pubmed_title><pmcid>PMC8043429</pmcid><pubmed_authors>Rauschning D</pubmed_authors><pubmed_authors>Mueller-Joerger G</pubmed_authors><pubmed_authors>Fuerst J</pubmed_authors><pubmed_authors>Nattermann J</pubmed_authors><pubmed_authors>Classen A</pubmed_authors><pubmed_authors>Rueddel J</pubmed_authors><pubmed_authors>Peetz H</pubmed_authors><pubmed_authors>Wille K</pubmed_authors><pubmed_authors>Bethge W</pubmed_authors><pubmed_authors>Gruener B</pubmed_authors><pubmed_authors>Prasser F</pubmed_authors><pubmed_authors>Koehler FC</pubmed_authors><pubmed_authors>Schubert J</pubmed_authors><pubmed_authors>Vehreschild JJ</pubmed_authors><pubmed_authors>Stieglitz S</pubmed_authors><pubmed_authors>Eberwein L</pubmed_authors><pubmed_authors>Keller U</pubmed_authors><pubmed_authors>Dolff S</pubmed_authors><pubmed_authors>Walter L</pubmed_authors><pubmed_authors>Hower M</pubmed_authors><pubmed_authors>von Bergwelt-Baildon M</pubmed_authors><pubmed_authors>Ritter A</pubmed_authors><pubmed_authors>Schulze N</pubmed_authors><pubmed_authors>Tometten L</pubmed_authors><pubmed_authors>Hohenstein B</pubmed_authors><pubmed_authors>Hanses F</pubmed_authors><pubmed_authors>Merle U</pubmed_authors><pubmed_authors>Vehreschild M</pubmed_authors><pubmed_authors>Ruthrich M</pubmed_authors><pubmed_authors>Raichle C</pubmed_authors><pubmed_authors>Ruethrich M</pubmed_authors><pubmed_authors>Hellwig K</pubmed_authors><pubmed_authors>Rieg S</pubmed_authors><pubmed_authors>Burst V</pubmed_authors><pubmed_authors>Spinner C</pubmed_authors><pubmed_authors>Heigener D</pubmed_authors><pubmed_authors>Friedrichs A</pubmed_authors><pubmed_authors>Franke B</pubmed_authors><pubmed_authors>Beutel G</pubmed_authors><pubmed_authors>Lablans M</pubmed_authors><pubmed_authors>Lanznaster J</pubmed_authors><pubmed_authors>Wettstein M</pubmed_authors><pubmed_authors>Droehmann D</pubmed_authors><pubmed_authors>Kielstein JT</pubmed_authors><pubmed_authors>Isberner N</pubmed_authors><pubmed_authors>Guggemos W</pubmed_authors><pubmed_authors>Rothfuss K</pubmed_authors><pubmed_authors>Neufang M</pubmed_authors><pubmed_authors>de With K</pubmed_authors><pubmed_authors>Pilgram L</pubmed_authors><pubmed_authors>Muller RU</pubmed_authors><pubmed_authors>Jakob CEM</pubmed_authors><pubmed_authors>Borgmann S</pubmed_authors><pubmed_authors>Stecher M</pubmed_authors><pubmed_authors>Degenhardt C</pubmed_authors><pubmed_authors>Trauth J</pubmed_authors><pubmed_authors>Worm M</pubmed_authors><pubmed_authors>Fuhrmann S</pubmed_authors><pubmed_authors>Weidemann A</pubmed_authors><pubmed_authors>Brandenburger T</pubmed_authors><pubmed_authors>Bals R</pubmed_authors><pubmed_authors>Piepel C</pubmed_authors><pubmed_authors>Jung N</pubmed_authors><pubmed_authors>LEOSS Study group</pubmed_authors><pubmed_authors>Schons M</pubmed_authors><pubmed_authors>Schultheis B</pubmed_authors><pubmed_authors>Prattes J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease.</name><description>&lt;h4>Purpose&lt;/h4>The ongoing pandemic caused by the novel severe acute respiratory coronavirus 2 (SARS-CoV-2) has stressed health systems worldwide. Patients with chronic kidney disease (CKD) seem to be more prone to a severe course of coronavirus disease (COVID-19) due to comorbidities and an altered immune system. The study's aim was to identify factors predicting mortality among SARS-CoV-2-infected patients with CKD.&lt;h4>Methods&lt;/h4>We analyzed 2817 SARS-CoV-2-infected patients enrolled in the Lean European Open Survey on SARS-CoV-2-infected patients and identified 426 patients with pre-existing CKD. Group comparisons were performed via Chi-squared test. Using univariate and multivariable logistic regression, predictive factors for mortality were identified.&lt;h4>Results&lt;/h4>Comparative ana</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2025-04-26T10:59:27.727Z</modification><creation>2022-02-11T06:25:49.192Z</creation></dates><accession>S-EPMC8043429</accession><cross_references><pubmed>33851328</pubmed><doi>10.1007/s15010-021-01597-7</doi></cross_references></HashMap>